| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AACR annual meeting 2012
|
Guha, Malini
|
|
2012
|
13 |
5 |
p. 454-
1 p.
|
artikel
|
| 2 |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
|
Yang, James Chih-Hsin
|
|
2012
|
13 |
5 |
p. 539-548
10 p.
|
artikel
|
| 3 |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
|
Miller, Vincent A
|
|
2012
|
13 |
5 |
p. 528-538
11 p.
|
artikel
|
| 4 |
A Monster Calls
|
O'Donoghue, Odhran
|
|
2012
|
13 |
5 |
p. 458-
1 p.
|
artikel
|
| 5 |
Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis
|
Machalek, Dorothy A
|
|
2012
|
13 |
5 |
p. 487-500
14 p.
|
artikel
|
| 6 |
A new generation of EGFR tyrosine-kinase inhibitors in NSCLC
|
Hirsch, Fred R
|
|
2012
|
13 |
5 |
p. 442-443
2 p.
|
artikel
|
| 7 |
A new option for relapsed or refractory Hodgkin's lymphoma
|
Sharma, Sharan Prakash
|
|
2012
|
13 |
5 |
p. e192-
1 p.
|
artikel
|
| 8 |
BRICS nations tackle non-communicable diseases
|
Burki, Talha Khan
|
|
2012
|
13 |
5 |
p. 451-
1 p.
|
artikel
|
| 9 |
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
|
James, Nicholas D
|
|
2012
|
13 |
5 |
p. 549-558
10 p.
|
artikel
|
| 10 |
Chasing the greenback and the decline in scientific rigour
|
The Lancet Oncology,
|
|
2012
|
13 |
5 |
p. 433-
1 p.
|
artikel
|
| 11 |
Coffee: the science and art of moderation
|
Krell, Jonathan
|
|
2012
|
13 |
5 |
p. 457-458
2 p.
|
artikel
|
| 12 |
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|
van den Eertwegh, Alfons JM
|
|
2012
|
13 |
5 |
p. 509-517
9 p.
|
artikel
|
| 13 |
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
|
Anderson, Garnet L
|
|
2012
|
13 |
5 |
p. 476-486
11 p.
|
artikel
|
| 14 |
CRUK: funding policy under scrutiny
|
Senior, Kathryn
|
|
2012
|
13 |
5 |
p. e194-
1 p.
|
artikel
|
| 15 |
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
|
Algra, Annemijn M
|
|
2012
|
13 |
5 |
p. 518-527
10 p.
|
artikel
|
| 16 |
Endangered species and cancer: protecting Noah's Ark
|
Dehnel, Tim
|
|
2012
|
13 |
5 |
p. 455-
1 p.
|
artikel
|
| 17 |
Endometriosis and ovarian cancer
|
Vercellini, Paolo
|
|
2012
|
13 |
5 |
p. e188-e189
nvt p.
|
artikel
|
| 18 |
Endometriosis and ovarian cancer
|
Guo, Sun-Wei
|
|
2012
|
13 |
5 |
p. e189-e190
nvt p.
|
artikel
|
| 19 |
Endometriosis and ovarian cancer – Authors' reply
|
Pearce, Celeste Leigh
|
|
2012
|
13 |
5 |
p. e190-
1 p.
|
artikel
|
| 20 |
Errata
|
|
|
2012
|
13 |
5 |
p. e186-
1 p.
|
artikel
|
| 21 |
Errata
|
|
|
2012
|
13 |
5 |
p. e186-
1 p.
|
artikel
|
| 22 |
Expensive US cancer care: value for money?
|
Furlow, Bryant
|
|
2012
|
13 |
5 |
p. e193-
1 p.
|
artikel
|
| 23 |
Fukushima: 1-year on
|
Burki, Talha Khan
|
|
2012
|
13 |
5 |
p. e193-
1 p.
|
artikel
|
| 24 |
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
|
Zhang, Li
|
|
2012
|
13 |
5 |
p. 466-475
10 p.
|
artikel
|
| 25 |
Global science funding in a tail spin?
|
Senior, Kathryn
|
|
2012
|
13 |
5 |
p. 452-
1 p.
|
artikel
|
| 26 |
Heterogeneity of induction failure in childhood ALL
|
Bennet, Neil
|
|
2012
|
13 |
5 |
p. e195-
1 p.
|
artikel
|
| 27 |
Integration of palliative and supportive cancer care in Asia
|
Chin, Jacqueline J
|
|
2012
|
13 |
5 |
p. 445-446
2 p.
|
artikel
|
| 28 |
Intensifying tumour immunity through combination therapy
|
Dranoff, Glenn
|
|
2012
|
13 |
5 |
p. 440-442
3 p.
|
artikel
|
| 29 |
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|
Madan, Ravi A
|
|
2012
|
13 |
5 |
p. 501-508
8 p.
|
artikel
|
| 30 |
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
|
Margolin, Kim
|
|
2012
|
13 |
5 |
p. 459-465
7 p.
|
artikel
|
| 31 |
Is benefit of maintenance therapy for NSCLC best defined by progression-free survival?
|
Reckamp, Karen L
|
|
2012
|
13 |
5 |
p. 435-436
2 p.
|
artikel
|
| 32 |
Mediastinal staging of lung cancer: novel concepts
|
Tournoy, Kurt G
|
|
2012
|
13 |
5 |
p. e221-e229
nvt p.
|
artikel
|
| 33 |
Melanoma molecular classes and prognosis in the postgenomic era
|
Tremante, Elisa
|
|
2012
|
13 |
5 |
p. e205-e211
nvt p.
|
artikel
|
| 34 |
Mutational analysis in AML aids risk stratification
|
Brower, Vicki
|
|
2012
|
13 |
5 |
p. e191-
1 p.
|
artikel
|
| 35 |
New report sets guidelines for omics research
|
MacReady, Norra
|
|
2012
|
13 |
5 |
p. e191-
1 p.
|
artikel
|
| 36 |
Nodal-staging surgery for locally advanced cervical cancer in the era of PET
|
Gouy, Sebastien
|
|
2012
|
13 |
5 |
p. e212-e220
nvt p.
|
artikel
|
| 37 |
No survival benefit of olaparib in ovarian cancer patients
|
Bennet, Neil
|
|
2012
|
13 |
5 |
p. e192-
1 p.
|
artikel
|
| 38 |
Oestrogen and breast cancer: results from the WHI trial
|
Howell, Anthony
|
|
2012
|
13 |
5 |
p. 437-438
2 p.
|
artikel
|
| 39 |
Overcoming resistance of cancer stem cells
|
Pignalosa, Diana
|
|
2012
|
13 |
5 |
p. e187-e188
nvt p.
|
artikel
|
| 40 |
Personalised medicine in oncology: questions for the next 20 years
|
Blay, Jean-Yves
|
|
2012
|
13 |
5 |
p. 448-449
2 p.
|
artikel
|
| 41 |
Phase 2 trial design in neuro-oncology revisited: a report from the RANO group
|
Galanis, Evanthia
|
|
2012
|
13 |
5 |
p. e196-e204
nvt p.
|
artikel
|
| 42 |
Placebo effect in hot flush research
|
Mahon, Suzanne M
|
|
2012
|
13 |
5 |
p. e188-
1 p.
|
artikel
|
| 43 |
Revolutionising cancer care in South Africa
|
Gouws, Leon
|
|
2012
|
13 |
5 |
p. 447-448
2 p.
|
artikel
|
| 44 |
Screening for anal cancer: endpoints needed
|
Wentzensen, Nicolas
|
|
2012
|
13 |
5 |
p. 438-440
3 p.
|
artikel
|
| 45 |
States and US Government spar over medical marijuana
|
Furlow, Bryant
|
|
2012
|
13 |
5 |
p. 450-
1 p.
|
artikel
|
| 46 |
Telecommunications in skin cancer prevention and diagnosis
|
Shum, Li
|
|
2012
|
13 |
5 |
p. 456-
1 p.
|
artikel
|
| 47 |
65th Cancer Symposium of the Society of Surgical Oncology
|
Smith, Lan-Lan
|
|
2012
|
13 |
5 |
p. 453-
1 p.
|
artikel
|
| 48 |
The STAMPEDE trial and celecoxib: how to adapt?
|
Armstrong, Andrew J
|
|
2012
|
13 |
5 |
p. 443-445
3 p.
|
artikel
|
| 49 |
Treatment of brain metastases in patients with melanoma
|
Fisher, Rosalie
|
|
2012
|
13 |
5 |
p. 434-435
2 p.
|
artikel
|
| 50 |
Voices from the front: May
|
Mastrianni, David M
|
|
2012
|
13 |
5 |
p. 458-
1 p.
|
artikel
|
| 51 |
Will plain packaging spell the end of tobacco marketing?
|
Kirby, Tony
|
|
2012
|
13 |
5 |
p. e195-
1 p.
|
artikel
|
Tijdschrift beschrijving